Structural

CT Interrogation & Procedure Simulations of Failing Surgical Valves

12 min.

Valve Fracturing During Surgical Valve-in-Valve Procedures

19 min.

How to Define and Manage Subclinical Leaflet Thrombosis

15 min.

Pathobiologic Insights From TAVR Explants

12 min.

Surgical Explants for Failed TAVR: Frequency, Outcomes, and Clinical Implications

6 min.

TAVR Durability: What Do We Know So Far?

5 min.

Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy

14 min.

Not All Valves Are Designed Alike

7 min.

Which endpoints and definitions matter for assessment of bioprosthetic valve durability following TAVR?

17 min.

Severe PPM and High Residual Gradient Are Frequent and Negatively Impact Outcomes Following TAVR (PRO)

14 min.

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

8 min.

Severe PPM and High Residual Gradient Are Frequent and Negatively Impact Outcomes Following TAVR (PRO)

6 min.

Cases 1/2 : TAVR at 8 Years and SVD at 2 Years

9 min.

Dealing With Hemopericardium, Retroperitoneal Bleeding, and Annular Disruption

17 min.

Tips and Tricks for TAVR Explantation

14 min.

SAVR After TAVR: A Dangerous Epidemic?

10 min.

Leaflet Modification for TAV-in-TAV

5 min.

The 2024 'Toolbox' for Leaflet Modification in TAVR

6 min.

The Coronary Access Conundrum in Revalving Strategies

12 min.

Projecting the Frequency of Failed Transcatheter Aortic Valves

15 min.

LIVE Case: New TAVR -The Heart Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

25 min.

Planning for Aortic and Mitral Valve-in-Valve: Deciding the Need for Leaflet Laceration

11 min.

Case 1: Bioprosthetic Aortic Valve Dysfunction

4 min.

The Promise of Next Generation Cerebral Embolic Protection Devices

16 min.

Practical Tips for Cerebral Embolic Protection: From Clinical Trials to Clinical Practice

13 min.

Modern Era Clinical Trial Strategies For Cerebral Embolic Protection Devices

17 min.

Pericardial Effusion After TAVR: Percutaneous Treatment Strategies

21 min.

Vascular Access Complications (Ascending Aorta to CFA) – Percutaneous Repair Strategies

13 min.

Incidence and Relevance of New-onset LBBB and PPM Implantation in the Current Era

15 min.

A Practical Guide to Reduce Conduction Disturbance After TAVR

15 min.

Post-TAVR Risk-Stratification for Conduction Disturbances

16 min.

Lessons From Off Label TAVR Use in Pure AR – Tips & Tricks

13 min.

Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial

13 min.

LIVE Case: TAVR in BAVD – NewYork-Presbyterian Columbia University Irving Medical Center, New York, NY

42 min.

Structural Keynote Lecture: Cerebral Microbleeds during TAVR: Imaging Findings and Clinical Relevance

10 min.

Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Study Cohort

10 min.

It Isn’t Over Until The Patient Leaves the Hospital: Conduction Disturbances, Medical Therapies, and Other Issues

12 min.

Conduction Disturbances: Prevention and Management

9 min.

Understanding the Magnitude and Importance of TAVR Complications in Modern Clinical Practice

15 min.

The Problem Is Not Gone: Assessing and Managing Paravalvular Leak

20 min.

Subclinical Leaflet Thrombosis: Detection and Management

9 min.

A Challenging Case of Subclinical Leaflet Thrombosis

3 min.

Clinical Valve Thrombosis: Diagnosis, Management, and Prognosis

14 min.

A Challenging Case of Clinical Valve Thrombosis

3 min.

Defining Valve Thrombosis: Making Sense of Alphabet Soup

5 min.

Prevention and Management of Coronary Obstruction in VIV-TAVR

9 min.

Keynote Lecture: Essentials of Multispecialty Management of Endocarditis

8 min.

Structural Keynote Lecture: A Practical Guide to Prevention and Management of Coronary Complications of TAVR

11 min.

Assessing the Risk of LV Failure After TAVR

15 min.

Structural Keynote Lecture: My Tips and Tricks for Managing the Unwanted Openings Post TAVR

10 min.

Predicting Ischemic and Bleeding Risk in Patients after PCI on DAPT: An Individualized Patient Centered Machine Learning Model

9 min.

Percutaneous Closure of Aortic to Right Ventricle Fistula After Transcatheter Aortic Valve Replacement: 3D Printing Saved the Day

13 min.

Aortic Stenosis TAVR With Annular Rupture/ Tamponade

14 min.

SPOTLIGHT LECTURE: Failed TAVR Management -Lessons Learned From Registry Experiences

14 min.

Case Presentation 3: Favoring TAVR Explant: When to Throw in the Towel and Operate

8 min.

Unusual cause of myocardial infarction following transcatheter aortic valve replacement

8 min.

Late coronary obstruction after TAVR

11 min.

Post valve-in-valve:  PCI and atherectomy in a patient with impossible-to-engage coronaries

9 min.

SAPIEN 3 TAVR Durability

22 min.

Future Interventions

18 min.

Why Long-Term Valve Performance Matter

11 min.

Lifetime Management of Aortic Stenosis: The Importance of Choosing the First Valve

16 min.

Case-Based Approach to Patients With Severe AS and MR (Degenerative and Functional)

11 min.

Ascending Aorta Dilation & TAVR vs SAVR: When Should it Matter?

15 min.

Position 1: Echo First and Only for Identification of Bioprosthetic Valve Dysfunction Following TAVR

7 min.

Position 2: Echo Overestimates Bioprosthetic Valve Gradients Following TAVR. Always Confirm With Invasive Assessment

6 min.

Clinical Implications of Prosthesis-Patient Mismatch and High Residual Gradients After AVR

26 min.

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

14 min.

Prevention and Management of Conduction Disturbances (With Case Examples)

12 min.

Prevention and Management of PVL: When to Intervene (With Case Examples)

9 min.

Protecting Coronary Access During TAVR (BASILICA, Snorkel Stenting, Commissural Alignment)

10 min.

Management of CAD Before and After TAVR

14 min.

SPOTLIGHT INNOVATION LECTURE: TAVR Innovation Priorities: From Short Term Outcomes to Lifetime Management

11 min.

TAVR Explant: What Every Interventionalist (and Surgeon) Needs to Know

8 min.

Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT?

9 min.

TCT 719: Subacute migration of balloon-expandable transcatheter aortic valve to ventricle in the Setting of Aortic Regurgitation

5 min.

TCT 770: S3 Ultra can be used to anchor the CoreValve in ventricular migration during transcatheter aortic valve replacement in pure aortic insufficiency

6 min.

Unveiling the Mechanisms of Transcatheter Valve Failure: Anatomical Location Does Matter!

13 min.